Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedAdvisor Limited ( (AU:MDR) ) has issued an announcement.
MedAdvisor Limited announced the results of its General Meeting, where resolutions 1 to 5 were passed, while resolutions concerning retention benefits for key executives were not approved. This outcome reflects shareholder engagement and may influence the company’s executive compensation strategy and stakeholder relations.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited is a leader in pharmacy-driven patient engagement solutions, providing personalized patient experiences to simplify the medication journey. Utilizing its cloud-based, AI-enabled platform THRiV, MedAdvisor enhances pharmacy workflows and patient engagement, working with over 34,000 pharmacies across the US and reaching over two-thirds of the population.
Average Trading Volume: 973,354
Technical Sentiment Signal: Sell
Current Market Cap: A$37.52M
Learn more about MDR stock on TipRanks’ Stock Analysis page.